Skip to content

Hormonal contraception safe for women with HIV and may have important health benefits

Patients of non-specialist HIV physicians often have poor ART outcomes and frequently receive sub-optimal care

Hepatitis C incidence remains stable among gay men living with HIV in Europe, but varies across countries

Maria Prins, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Post-treatment control of HIV appears rare, biomarkers may help predict viral rebound

Many HIV transmissions in sero-discordant couples occuring at CD4 cell counts above ART eligibility threshold

Priorities for HIV care: the perspectives of healthcare providers and patients

Sofosbuvir/ledipasvir for 8 weeks cures most hard-to-treat hepatitis C patients in real-world study

Patrick Ingiliz, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Successful hepatitis C treatment lowers risk of death for people with HIV and HCV co-infection

Lars Peters, presenting at EACS 2015. Photo by Liz Highleyman, hivandhepatitis.com

Strategies for hepatitis C ‘treatment as prevention’ must address the concerns of people who inject drugs

Conference delegates protest against the unaffordability of hepatitis C treatment. Photograph © 2015 Ahmad Yusni/Harm Reduction International.